Terms: = Lung cancer AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396 AND Prognosis
32 results:
1. The possible correlation between miR-762, Hippo signaling pathway, TWIST1, and smad3 in lung cancer and chronic inflammatory diseases.
Hussein NA; Ebid SA; Ahmad MA; Khedr GE; Saad DM
Sci Rep; 2024 Apr; 14(1):8246. PubMed ID: 38589525
[TBL] [Abstract] [Full Text] [Related]
2. Single-cell transcriptomic sequencing data reveal aberrant DNA methylation in smad3 promoter region in tumor-associated fibroblasts affecting molecular mechanism of radiosensitivity in non-small cell lung cancer.
Han F; Chen S; Zhang K; Zhang K; Wang M; Wang P
J Transl Med; 2024 Mar; 22(1):288. PubMed ID: 38493128
[TBL] [Abstract] [Full Text] [Related]
3. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
4. POH1 induces smad3 deubiquitination and promotes lung cancer metastasis.
Yuan Y; Li Y; Wu X; Bo J; Zhang L; Zhang J; Hu Y; Chen Y; Zeng Y; Wei X; Zhang H
Cancer Lett; 2024 Feb; 582():216526. PubMed ID: 38061486
[TBL] [Abstract] [Full Text] [Related]
5. Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR-1343-3p/Bcl-3 axis through TGFβ/smad3/EMT signaling.
Ge P; Chen X; Liu J; Jing R; Zhang X; Li H
Mol Carcinog; 2023 Jul; 62(7):1073-1085. PubMed ID: 37132942
[TBL] [Abstract] [Full Text] [Related]
6. Uncovering the dynamic effects of DEX treatment on lung cancer by integrating bioinformatic inference and multiscale modeling of scRNA-seq and proteomics data.
Chen M; Xu C; Xu Z; He W; Zhang H; Su J; Song Q
Comput Biol Med; 2022 Oct; 149():105999. PubMed ID: 35998480
[TBL] [Abstract] [Full Text] [Related]
7. RNA
Tan B; Zhou K; Liu W; Prince E; Qing Y; Li Y; Han L; Qin X; Su R; Pokharel SP; Yang L; Zhao Z; Shen C; Li W; Chen Z; Zhang Z; Deng X; Small A; Wang K; Leung K; Chen CW; Shen B; Chen J
Theranostics; 2022; 12(13):5727-5743. PubMed ID: 35966596
[TBL] [Abstract] [Full Text] [Related]
8. Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma.
Duch P; Díaz-Valdivia N; Ikemori R; Gabasa M; Radisky ES; Arshakyan M; Gea-Sorlí S; Mateu-Bosch A; Bragado P; Carrasco JL; Mori H; Ramírez J; Teixidó C; Reguart N; Fillat C; Radisky DC; Alcaraz J
Matrix Biol; 2022 Aug; 111():207-225. PubMed ID: 35787446
[TBL] [Abstract] [Full Text] [Related]
9. PTBP3 mediates TGF-β-induced EMT and metastasis of lung adenocarcinoma.
Dong C; Wu K; Gu S; Wang W; Xie S; Zhou Y
Cell Cycle; 2022 Jul; 21(13):1406-1421. PubMed ID: 35323096
[TBL] [Abstract] [Full Text] [Related]
10. α5-nAChR associated with Ly6E modulates cell migration via TGF-β1/smad signaling in non-small cell lung cancer.
Zhang Q; Jia Y; Pan P; Zhang X; Jia Y; Zhu P; Chen X; Jiao Y; Kang G; Zhang L; Ma X
Carcinogenesis; 2022 May; 43(4):393-404. PubMed ID: 34994389
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic Significance of TLR2, smad3 and Localization-dependent SATB1 in Stage I and II Non-Small-Cell lung cancer Patients.
Durślewicz J; Klimaszewska-Wiśniewska A; Jóźwicki J; Antosik P; Smolińska-Świtała M; Gagat M; Kowalewski A; Grzanka D
Cancer Control; 2021; 28():10732748211056697. PubMed ID: 34818944
[TBL] [Abstract] [Full Text] [Related]
12. Cisplatin prevents breast cancer metastasis through blocking early EMT and retards cancer growth together with paclitaxel.
Wang H; Guo S; Kim SJ; Shao F; Ho JWK; Wong KU; Miao Z; Hao D; Zhao M; Xu J; Zeng J; Wong KH; Di L; Wong AH; Xu X; Deng CX
Theranostics; 2021; 11(5):2442-2459. PubMed ID: 33500735
[TBL] [Abstract] [Full Text] [Related]
13. EEF1A2 interacts with HSP90AB1 to promote lung adenocarcinoma metastasis via enhancing TGF-β/smad signalling.
Jia L; Ge X; Du C; Chen L; Zhou Y; Xiong W; Xiang J; Li G; Xiao G; Fang L; Li Z
Br J Cancer; 2021 Mar; 124(7):1301-1311. PubMed ID: 33473168
[TBL] [Abstract] [Full Text] [Related]
14. Platelet lysates in Hepatocellular Carcinoma patients after radiofrequency ablation facilitate tumor proliferation, invasion and vasculogenic mimicry.
Jia G; Kong J; Yao C; Wu S; Sun W
Int J Med Sci; 2020; 17(14):2104-2112. PubMed ID: 32922171
[No Abstract] [Full Text] [Related]
15. Knockdown of smad3 inhibits the growth and enhances the radiosensitivity of lung adenocarcinoma via p21
Niu H; Huang Y; Yan L; Zhang L; Zhao M; Lu T; Yang X; Chen Z; Zhan C; Shi Y; Wang Q
Int J Biol Sci; 2020; 16(6):1010-1022. PubMed ID: 32140069
[TBL] [Abstract] [Full Text] [Related]
16. Altered expression of fucosylation pathway genes is associated with poor prognosis and tumor metastasis in non‑small cell lung cancer.
Park S; Lim JM; Chun JN; Lee S; Kim TM; Kim DW; Kim SY; Bae DJ; Bae SM; So I; Kim HG; Choi JY; Jeon JH
Int J Oncol; 2020 Feb; 56(2):559-567. PubMed ID: 31894325
[TBL] [Abstract] [Full Text] [Related]
17. Sodium Arsenite Inhibits lung Fibroblast Differentiation and Pulmonary Fibrosis.
Jiao H; Song J; Sun X; Sun D; Zhong M
Pharmacology; 2019; 104(5-6):368-376. PubMed ID: 31553994
[TBL] [Abstract] [Full Text] [Related]
18. HCP5 is a smad3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
[No Abstract] [Full Text] [Related]
19. Long Noncoding RNA
Sakai S; Ohhata T; Kitagawa K; Uchida C; Aoshima T; Niida H; Suzuki T; Inoue Y; Miyazawa K; Kitagawa M
Cancer Res; 2019 Jun; 79(11):2821-2838. PubMed ID: 30952633
[TBL] [Abstract] [Full Text] [Related]
20. EPB41L5 Mediates TGFβ-Induced Metastasis of Gastric cancer.
Jeong MH; Park SY; Lee SH; Seo J; Yoo JY; Park SH; Kim MJ; Lee S; Jang S; Choi HK; Lee JE; Shin SJ; Choi KC; Cheong JH; Yoon HG
Clin Cancer Res; 2019 Jun; 25(12):3617-3629. PubMed ID: 30814110
[TBL] [Abstract] [Full Text] [Related]
[Next]
